Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $2.5 million.

  • Accendra Health's Gains from Investment Securities rose 17577.78% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 9046.81%. This contributed to the annual value of $5.1 million for FY2024, which is 6257.57% up from last year.
  • As of Q3 2025, Accendra Health's Gains from Investment Securities stood at $2.5 million, which was up 17577.78% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Gains from Investment Securities registered a high of $67.1 million during Q2 2021, and its lowest value of $405000.0 during Q4 2022.
  • In the last 5 years, Accendra Health's Gains from Investment Securities had a median value of $7.8 million in 2022 and averaged $10.6 million.
  • Per our database at Business Quant, Accendra Health's Gains from Investment Securities tumbled by 9743.57% in 2022 and then skyrocketed by 197901.23% in 2023.
  • Quarter analysis of 5 years shows Accendra Health's Gains from Investment Securities stood at $15.8 million in 2021, then plummeted by 97.44% to $405000.0 in 2022, then skyrocketed by 1979.01% to $8.4 million in 2023, then decreased by 16.59% to $7.0 million in 2024, then crashed by 64.66% to $2.5 million in 2025.
  • Its Gains from Investment Securities stands at $2.5 million for Q3 2025, versus $1.3 million for Q2 2025 and $5.4 million for Q1 2025.